Early prognostic indicators in primary perinatal human immunodeficiency virus type 1 infection: importance of viral RNA and the timing of transmission on long-term outcome

J Infect Dis. 1998 Aug;178(2):375-87. doi: 10.1086/515637.

Abstract

The time of perinatal human immunodeficiency virus type 1 (HIV-1) transmission and the pattern of early plasma viremia as predictors of disease progression were evaluated in infected infants followed from birth. Cox proportional hazards modeling demonstrated that a 1-log higher HIV-1 RNA copy number at birth was associated with a 40% increase in the relative hazard (RH) of developing CDC class A or B symptoms (P = .004), a 60% increase in developing AIDS (P = .01), and an 80% increase in the of risk death (P = .023) over the follow-up period of up to 8 years. The peak HIV-1 RNA copy number for infants during primary viremia was also predictive of progression to AIDS (RH, 9.9; 95% confidence interval [95% CI], 1.8-54.1; P = .008) and death (RH, 6.9; 95% CI, 1.1-43.8; P = .04). The results indicate that high levels of HIV-1 RNA at birth and during primary viremia are associated with early onset of symptoms and rapid disease progression to AIDS and death in perinatally infected children.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Acquired Immunodeficiency Syndrome / physiopathology
  • Acquired Immunodeficiency Syndrome / virology
  • Age of Onset
  • Anti-HIV Agents / therapeutic use
  • Child
  • Child, Preschool
  • Follow-Up Studies
  • HIV Infections / drug therapy
  • HIV Infections / immunology
  • HIV Infections / transmission*
  • HIV Infections / virology*
  • HIV-1* / genetics
  • Humans
  • Infant
  • Infant, Newborn
  • Longitudinal Studies
  • Prognosis
  • Prospective Studies
  • RNA, Viral / blood*
  • Reverse Transcriptase Inhibitors / therapeutic use
  • Time Factors
  • Viral Load*
  • Zidovudine / therapeutic use

Substances

  • Anti-HIV Agents
  • RNA, Viral
  • Reverse Transcriptase Inhibitors
  • Zidovudine